ArticleScientific reports2026
Ultra-high resolution OCT imaging reveals retinal layer degeneration in RD10 mice with comparison to commercial standard resolution OCT.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Split-spectrum amplitude decorrelation optoretinography for functional imaging of mouse photoreceptors.Biomedical optics express · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Optical coherence tomography (OCT) imaging gives researchers a window into the structure-function relationships of the retina. This makes OCT a great tool for studying photoreceptor degeneration in vivo in mouse models of inherited retinal diseases like retinitis pigmentosa (RP). RP is a leading cause of blindness in individuals under 40 and has no approved treatment. In this study, we present a custom ultra-high resolution spectral domain optical coherence tomography (UHR-OCT) system for imaging the mouse retina with an axial resolution of 2.38 µm in air. First, we qualitatively and quantitatively compared imaging performance of our UHR-OCT to a commercially available OCT system (Heidelberg Spectralis OCT) and demonstrated that our system can resolve additional fine retinal cell layers compared to the commercial system and accurately measure their thickness. Using our UHR-OCT system, we measured thickness changes in retinal cell layers in retinal degeneration 10 (RD10) and compared them to those of wild type (WT) mice. We showed that RD10 mice have thinner retinas than WT mice, and that this retinal thinning was primarily associated with thinning of the outer nuclear layer and degradation of the photoreceptor inner and outer segment. This study demonstrates the utility of UHR-OCT for imaging fine retinal cell layers in the mouse retina with high resolution. Higher resolution OCT for mouse imaging could help researchers better understand inherited retinal diseases like RP in mouse models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.